6,7-MODIFIZIERTE-11(BETA)-ARYL-4-ESTRENE

Compounds have general formula (I), in which X stands for an oxygen atom or for the hydroxyimino grouping >N SIMILAR OH; R stands for a hydrogen atom or for a methyl group; G stands for a hydrogen, halogen atom, a C1-C4 alkyl residue, when M and Q stand for hydrogen atoms or for a common addition...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ELGER, WALTER, OTTOW, ECKHARD, CLEVE, ARWED, FUHRMANN, ULRIKE-BIOL. DR., 1000 BERLIN, DE, SCHWEDE, WOLFGANG, CHWALISZ, KRZYSZTOF, SCHNEIDER, MARTIN
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS STEROIDS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds have general formula (I), in which X stands for an oxygen atom or for the hydroxyimino grouping >N SIMILAR OH; R stands for a hydrogen atom or for a methyl group; G stands for a hydrogen, halogen atom, a C1-C4 alkyl residue, when M and Q stand for hydrogen atoms or for a common additional bond; Q stands for a C1-C4 alkyl residue when M and G stand for hydrogen atoms; and G and M represent together a methylene or ethylene group when Q stands for a hydrogen atom; R , R and R have the meanings given in the description. These new compounds have strong antigestagenous, antiglucocorticoidal, antimineralcorticoidal and antiandrogenous properties and are useful for producing medicaments.